Cancer
To meet the medical needs of patients, we have made oncology one of our priorities.
THERAPEUTIC AREAS
Listening to patients to provide them with the most effective solutions
Every day, Servier helps to treat patients in over 150 countries using its extensive range of brand-name and generic medicines. We have developed a balanced portfolio of medicines across our various therapeutic areas.
In each of these domains, we listen to patients to provide them with the most effective solutions.
We are a world leading pharmaceutical group in cardiology and the treatment of venous diseases. In oncology, we are moving up a gear to become a focused and innovative player. We are also involved in metabolic diseases, neuroscience and immune-inflammatory diseases. To increase the pace of innovation oriented to meet patient needs, we champion collaboration and constant dialogue between those involved in health care in both the public and private sectors, it takes an open and collaborative approach, working with academic partners, pharmaceutical groups and biotech companies.
We put patients and innovation at the heart of everything we do. To meet their needs, we work with patients at every stage of the medicine life cycle—from research to appropriate use—before, during and after treatment.
We believe it is essential. For science. For patients.
Focus
30 medicines available to patients in over 150 countries